跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
An-107
首页
药物
An-107
An-107
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US 7812218 B2
申请人: EVOGENE LTD
优先权: 2004
CN
US
9 件公开
Targeting MicroRNAs for metabolic disorders
US 8592388 B2
申请人: STOFFEL MARKUS
优先权: 2010
US
9 件公开
Peptides and related molecules that bind to TALL-1
US 7259137 B2
申请人: AMGEN INC
优先权: 2002
US
7 件公开
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US 7919109 B2
申请人: INTARCIA THERAPEUTICS INC
优先权: 2008
US
7 件公开
C. novyi for the treatment of solid tumors in humans
US 10617723 B2
申请人: BIOMED VALLEY DISCOVERIES INC
优先权: 2013
US
WO
6 件公开
Pharmaceutically compatible method for purifying intact bacterial minicells
US 7611885 B2
申请人: ENGENEIC MOLECULAR DELIVERY PTY LTD
优先权: 2003
US
6 件公开
Treatment of vocal cords with autologous dermal fibroblast formulation
US 8765121 B2
申请人: MASLOWSKI JOHN
优先权: 2011
US
6 件公开
Dosage unit formulations of autologous dermal fibroblasts
US 8529883 B2
申请人: MASLOWSKI JOHN M
优先权: 2010
CN
US
5 件公开
DUAL MICROBIAL PREPARATION FOR LONG-TERM SUPPRESSION OR PREVENTION OF SYMPTOMS OF OPPORTUNISTIC MICROBIAL INFECTIONS
US 2018000877 A1
申请人: BIO AGENS RES AND DEVELOPMENT - BARD S R O
优先权: 2015
CN
EP
US
WO
4 件公开
TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA
EP 4619016 A4
申请人: INDAPTUS THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈